Misinterpretation with norm-based scoring of health status in adults with type 1 diabetes

Health and Quality of Life Outcomes

Volumn 4, Issue , 2006, Pages

  Supina, Alison L ^a   Feeny, David H ^b,c   Carroll, Linda J ^b   Johnson, Jeffrey A ^b,d  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c Health Utilities Incorporated   (Canada)

^d INSTITUTE OF HEALTH ECONOMICS   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; ARTICLE; CANADA; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; HEALTH STATUS; HEALTH SURVEY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; POPULATION DISTRIBUTION; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; SCORING SYSTEM; SELF REPORT; SOCIAL STATUS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; ALGORITHM; ATTITUDE TO HEALTH; HEALTH STATUS INDICATOR; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; REFERENCE VALUE; SICKNESS IMPACT PROFILE;

ADULT; ALBERTA; ALGORITHMS; ATTITUDE TO HEALTH; DATA INTERPRETATION, STATISTICAL; DIABETES MELLITUS, TYPE 1; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; PSYCHOMETRICS; QUALITY OF LIFE; REFERENCE VALUES; SICKNESS IMPACT PROFILE;

EID: 33645473713     PISSN: 14777525     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-4-15     Document Type: Article

References (43)

1. Lydick E, Epstein RS. Interpretation of quality of life changes. Qual Life Res 1993, 2:221-226.
2. Guyatt GH, Osobora D, Wu A, Wyrwich KW, Norman GR, the Clinical Significance Consensus Meeting Group: Methods to explain the clinical significance of health status measures. Mayo Clin Proc 2002, 77:371-383.
3. Cella D, Bullinger M, Scott C, Barofsky I, the Clinical Significance Consensus Meeting Group: Group vs. individual approaches to understanding the clinical significance of differences or changes in quality of life. Mayo Clin Proc 2002, 77:384-392.
4. Crosby CD, Kolotkin RL, Williams GR: Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 2003, 56:395-407.
5. Guyatt GH, Feeny DH, Patrick DL: Measuring health-related quality of life. Ann Intern Med 1993, 118:622-629.
6. Luscombe FA. Health-related quality of life measurement in type 2 diabetes. Value Health 2000, 3:SI5-S28.
7. MacKeigan LD, Pathak DS: Overview of health-related quality of life measures. Am J Hosp Pharm 1992, 49:226-245.
8. Feeny DH, Furlong WJ, Torrance GW, Goldsmith CH, Ma ZZ, DePauw S, Denton M, Boyle M: Health Utilities Index. Multiattribute and single-attribute utility functions for the Health Utilities Index Mark 3 system. Med Care 2002, 40:113-128.
9. Ware JE, Kosinski M, James D: How to score version 2 of the SF-36® Health Survey (Standard & Acute Forms) Lincoln, RI: Quality Metric Incorporated; 2000.
10. Hays RD: RAND-36 Health Status Inventory San Antonio: The Psychological Corporation; 1998.
11. Tabaei BP, Shill-Novak J, Brandle R, Kaplan RM, Herman WH: Glycemia and the quality of well-being in patients with diabetes. Qual Life Res 2004, 13:1153-1161.
12. Coffey JT, Brandle M, Zhou H, Marriott D, Burke R: Valuing health-related quality of life in diabetes. Diabetes Care 2002, 25:2238-2243.
13. Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE, Wolffenbuttel BH, Niessen LW. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care 2002, 25:458-463.
14. Koopmanschap M: Coping with type II diabetes: the patient's perspective. Diabetologia 2002, 45:S18-22.
15. Hahl J, Hämäläinen H, Sintonen H, Simell T, Arinen S, Simell O: Health-related quality of life in type 1 diabetes without or with symptoms of long-term complications. Qual Life Res 2002, 11:427-436.
16. UK Prospective Diabetes Study Group: Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care 1999, 22:1125-1136.
17. Statistics Canada: National Population Health Survey, Cycle 2 Documentation.
18. Drummond, Michael: Introducing Economic and Quality of Life Measurements into Clinical Studies. Ann Med 2001, 33:344-349.
19. Horsman J, Furlong W, Feeny D, Torrance G: The Health Utilities Index (HUI®): concepts, measurement properties and applications. Health Qual Life Outcomes 2003, 1:54.
20. Boyle MH, Furlong W, Feeny D, Torrance G, Hatcher J: Reliability of the Health Utilities Index - Mark III used in the 1991 Cycle 6 General Social Survey Health Questionnaire. Qual Life Res 1995, 4:249-257.
21. Fisk JD, Brown MG, Sketris IS, Metz LM, Murray TJ, Stadnyk KJ: A comparison of health utility measures for the evaluation of multiple sclerosis treatments. J Neural Neurosurg Psychiatry 2005, 76:58-63.
22. Jones CA, Feeny D, Eng K: Test-retest reliability of Health Utilities Index scores: evidence from hip fracture. Int J Technol Assess Health Care 2005, 21:393-398.
23. Marra CA, Rashidi AA, Guh D, Kopec JA, Abrahamowicz M, Esdaile JM, Brazier JE, Fortin PR, Anis AH: Are indirect utility measures reliable and responsive in rheumatoid arthritis patients. Qual Life Res 2005, 14:1333-1344.
24. Thoma A, Sprague S, Veltri K, Duku E, Furlong W. Methodology and measurement properties of health-related quality of life instruments: a prospective study of patients undergoing breast reduction surgery. Health Qual Life Outcomes 2005, 3:44.
25. Maddigan SL, Feeny DH, Johnson JA, For the DOVE Investigators: A comparison of the Health Utilities Index Mark 2 and Mark 3 in type 2 diabetes. Med Decis Making 2003, 23:489-501.
26. Maddigan SL, Feeny DH, Johnson JA: Construct validity of the RAND-12 and Health Utilities Index Mark 2 and Mark 3 in type 2 diabetes. Qual Life Res 2004, 13:435-448.
27. Johnson JA, Nowatzki TE, Coons SJ: Health-related quality of life of diabetic Pima Indians. Med Care 1996, 34:97-102.
28. The Diabetes Control and Complications Trial Research Group, Shamoon H, Duffy H, Fleischer N: The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N Engi J Med 1993, 329:977-984.
29. Birbeck GI, Kim S, Hays RD, Vickery BG: Quality of life measures in epilepsy. How well can they detect change over time? Neurology 2000, 54:1822-1827.
30. Johnson JA, Maddigan SL: Performance of the RAND-12 and SF-12 summary scores in type 2 diabetes. Qual Life Res 2004, 13:449-456.
31. Hays RD, Morales LS: The RAND-36 measure of health-related quality of life. Ann Med 2001, 33:350-357.
32. Jacobson AM, de Groot M, Samson JA. The evaluation of two measures of quality of life in type 1 and type 2 diabetes. Diabetes Care 1994, 17:267-274.
33. Wyrwich KW, Tierney WM, Babu AN, Kroenk K, Wolinsky FD: A comparison of clinically important differences in health-related quality of life for patients with chronic lung disease, asthma, or heart disease. Health Serv Res 2005, 40:577-591.
34. Haapanen N, Miilunpalo S, Pasanen M, Oja P, Vuori I: Agreement between questionnaire data and medical records of chronic diseases in middle-aged and elderly Finnish men and women. Am J Epidemiol 1997, 145:762-769.
35. Kehoe R, Wu SY, Leske MC, Chylack LT: Comparing self-reported and physician-reported medical history. Am J Epidemiol 1994, 139:813-818.
36. Martin LM, Leff M, Calonge N, Garrett C, Nelson DE: Validation of self-reported chronic conditions and health services in a managed care population. Am J Prev Med 2000, 18:215-218.
37. Maddigan SL, Feeny DH, Johnson JA: Health-related quality of life deficits associated with diabetes and co morbidities in a Canadian national population health survey. Qual Life Res 2005, 14:1311-1320.
38. Alberta First Census Division Profiles [http://www.albertafirst.com/ profiles/cd/]
39. Hux Janet, Mei Tang: Patterns of Prevalence and Incidence of Diabetes. In Diabetes in Ontario: An ICES Practice Atlas Edited by: Hux JE, Booth GL, Slaughter PM, Laupacis A. Institute for Clinical Evaluative Sciences; 2003:1.2-1.3.
40. Oliver Matthew J, Charmaine Lok E, Jane Shi, Deanna Rothwell M: Dialysis Therapy for Persons with Diabetes. In Diabetes in Ontario: An ICES Practice Atlas Edited by: Hux JE, Booth GL, Slaughter PM, Laupacis A, Institute for Clinical Evaluative Sciences; 2003:8.166-8.167.
41. Bailes BK: Diabetes mellitus and its chronic complications. AORN 2002, 76(2):266-80.
42. Orchard TJ, Dorman JS, Maser RE, et al.: Prevalence of complications in IDDM by sex and duration: Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 1990, 39:1116-24.
43. Bakaris G: Risk factors for diabetic nephropathy. In UpToDate Edited b: Rose BD. UpToDate, Wellesley, WA, 2001.